United States Transdermal Drug Delivery System Market Report 2017

Publisher Name :
Date: 22-Nov-2017
No. of pages: 113
Inquire Before Buying

In this report, the United States Transdermal Drug Delivery System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Transdermal Drug Delivery System in these regions, from 2012 to 2022 (forecast).

United States Transdermal Drug Delivery System market competition by top manufacturers/players, with Transdermal Drug Delivery System sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- Hisamitsu

- Mylan

- GSK

- Novartis

- Teve (Actavis)

- Johnson & Johnson

- Lohmann

- Teikoku Seiyaku

- Bayer

- Lingrui

- Sanofi

- Qizheng

- Endo

- Huarun 999

- Haw Par

- Nichiban

- Mentholatum Company

- Laboratoires Genevrier

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Fentanyl

- Nitroglycerin

- Estradiol

- Nicotine

- Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- OTC

- Rx

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Transdermal Drug Delivery System Market Report 2017

Table of Contents
United States Transdermal Drug Delivery System Market Report 2017
1 Transdermal Drug Delivery System Overview
1.1 Product Overview and Scope of Transdermal Drug Delivery System
1.2 Classification of Transdermal Drug Delivery System by Product Category
1.2.1 United States Transdermal Drug Delivery System Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Transdermal Drug Delivery System Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Fentanyl
1.2.4 Nitroglycerin
1.2.5 Estradiol
1.2.6 Nicotine
1.2.7 Other
1.3 United States Transdermal Drug Delivery System Market by Application/End Users
1.3.1 United States Transdermal Drug Delivery System Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 OTC
1.3.3 Rx
1.4 United States Transdermal Drug Delivery System Market by Region
1.4.1 United States Transdermal Drug Delivery System Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Transdermal Drug Delivery System Status and Prospect (2012-2022)
1.4.3 Southwest Transdermal Drug Delivery System Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Transdermal Drug Delivery System Status and Prospect (2012-2022)
1.4.5 New England Transdermal Drug Delivery System Status and Prospect (2012-2022)
1.4.6 The South Transdermal Drug Delivery System Status and Prospect (2012-2022)
1.4.7 The Midwest Transdermal Drug Delivery System Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Transdermal Drug Delivery System (2012-2022)
1.5.1 United States Transdermal Drug Delivery System Sales and Growth Rate (2012-2022)
1.5.2 United States Transdermal Drug Delivery System Revenue and Growth Rate (2012-2022)
2 United States Transdermal Drug Delivery System Market Competition by Players/Suppliers
2.1 United States Transdermal Drug Delivery System Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Transdermal Drug Delivery System Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Transdermal Drug Delivery System Average Price by Players/Suppliers (2012-2017)
2.4 United States Transdermal Drug Delivery System Market Competitive Situation and Trends
2.4.1 United States Transdermal Drug Delivery System Market Concentration Rate
2.4.2 United States Transdermal Drug Delivery System Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Transdermal Drug Delivery System Manufacturing Base Distribution, Sales Area, Product Type
3 United States Transdermal Drug Delivery System Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Transdermal Drug Delivery System Sales and Market Share by Region (2012-2017)
3.2 United States Transdermal Drug Delivery System Revenue and Market Share by Region (2012-2017)
3.3 United States Transdermal Drug Delivery System Price by Region (2012-2017)
4 United States Transdermal Drug Delivery System Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Transdermal Drug Delivery System Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Transdermal Drug Delivery System Revenue and Market Share by Type (2012-2017)
4.3 United States Transdermal Drug Delivery System Price by Type (2012-2017)
4.4 United States Transdermal Drug Delivery System Sales Growth Rate by Type (2012-2017)
5 United States Transdermal Drug Delivery System Sales (Volume) by Application (2012-2017)
5.1 United States Transdermal Drug Delivery System Sales and Market Share by Application (2012-2017)
5.2 United States Transdermal Drug Delivery System Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Transdermal Drug Delivery System Players/Suppliers Profiles and Sales Data
6.1 Hisamitsu
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Hisamitsu Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Mylan
6.2.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Mylan Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 GSK
6.3.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 GSK Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novartis
6.4.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Teve (Actavis)
6.5.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Teve (Actavis) Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
6.6.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Johnson & Johnson Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Lohmann
6.7.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Lohmann Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Teikoku Seiyaku
6.8.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Bayer
6.9.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Bayer Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Lingrui
6.10.2 Transdermal Drug Delivery System Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Lingrui Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Sanofi
6.12 Qizheng
6.13 Endo
6.14 Huarun 999
6.15 Haw Par
6.16 Nichiban
6.17 Mentholatum Company
6.18 Laboratoires Genevrier
7 Transdermal Drug Delivery System Manufacturing Cost Analysis
7.1 Transdermal Drug Delivery System Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Transdermal Drug Delivery System
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Transdermal Drug Delivery System Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Transdermal Drug Delivery System Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Transdermal Drug Delivery System Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Transdermal Drug Delivery System Sales Volume Forecast by Type (2017-2022)
11.3 United States Transdermal Drug Delivery System Sales Volume Forecast by Application (2017-2022)
11.4 United States Transdermal Drug Delivery System Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Transdermal Drug Delivery System
Figure United States Transdermal Drug Delivery System Market Size (K Units) by Type (2012-2022)
Figure United States Transdermal Drug Delivery System Sales Volume Market Share by Type (Product Category) in 2016
Figure Fentanyl Product Picture
Figure Nitroglycerin Product Picture
Figure Estradiol Product Picture
Figure Nicotine Product Picture
Figure Other Product Picture
Figure United States Transdermal Drug Delivery System Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Transdermal Drug Delivery System by Application in 2016
Figure OTC Examples
Table Key Downstream Customer in OTC
Figure Rx Examples
Table Key Downstream Customer in Rx
Figure United States Transdermal Drug Delivery System Market Size (Million USD) by Region (2012-2022)
Figure The West Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Transdermal Drug Delivery System Sales (K Units) and Growth Rate (2012-2022)
Figure United States Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Transdermal Drug Delivery System Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Transdermal Drug Delivery System Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Transdermal Drug Delivery System Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Transdermal Drug Delivery System Sales Share by Players/Suppliers
Figure 2017 United States Transdermal Drug Delivery System Sales Share by Players/Suppliers
Figure United States Transdermal Drug Delivery System Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Transdermal Drug Delivery System Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Transdermal Drug Delivery System Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Transdermal Drug Delivery System Revenue Share by Players/Suppliers
Figure 2017 United States Transdermal Drug Delivery System Revenue Share by Players/Suppliers
Table United States Market Transdermal Drug Delivery System Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Transdermal Drug Delivery System Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Transdermal Drug Delivery System Market Share of Top 3 Players/Suppliers
Figure United States Transdermal Drug Delivery System Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Transdermal Drug Delivery System Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Transdermal Drug Delivery System Product Category
Table United States Transdermal Drug Delivery System Sales (K Units) by Region (2012-2017)
Table United States Transdermal Drug Delivery System Sales Share by Region (2012-2017)
Figure United States Transdermal Drug Delivery System Sales Share by Region (2012-2017)
Figure United States Transdermal Drug Delivery System Sales Market Share by Region in 2016
Table United States Transdermal Drug Delivery System Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Transdermal Drug Delivery System Revenue Share by Region (2012-2017)
Figure United States Transdermal Drug Delivery System Revenue Market Share by Region (2012-2017)
Figure United States Transdermal Drug Delivery System Revenue Market Share by Region in 2016
Table United States Transdermal Drug Delivery System Price (USD/Unit) by Region (2012-2017)
Table United States Transdermal Drug Delivery System Sales (K Units) by Type (2012-2017)
Table United States Transdermal Drug Delivery System Sales Share by Type (2012-2017)
Figure United States Transdermal Drug Delivery System Sales Share by Type (2012-2017)
Figure United States Transdermal Drug Delivery System Sales Market Share by Type in 2016
Table United States Transdermal Drug Delivery System Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Transdermal Drug Delivery System Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Transdermal Drug Delivery System by Type (2012-2017)
Figure Revenue Market Share of Transdermal Drug Delivery System by Type in 2016
Table United States Transdermal Drug Delivery System Price (USD/Unit) by Types (2012-2017)
Figure United States Transdermal Drug Delivery System Sales Growth Rate by Type (2012-2017)
Table United States Transdermal Drug Delivery System Sales (K Units) by Application (2012-2017)
Table United States Transdermal Drug Delivery System Sales Market Share by Application (2012-2017)
Figure United States Transdermal Drug Delivery System Sales Market Share by Application (2012-2017)
Figure United States Transdermal Drug Delivery System Sales Market Share by Application in 2016
Table United States Transdermal Drug Delivery System Sales Growth Rate by Application (2012-2017)
Figure United States Transdermal Drug Delivery System Sales Growth Rate by Application (2012-2017)
Table Hisamitsu Basic Information List
Table Hisamitsu Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hisamitsu Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Hisamitsu Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Hisamitsu Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Mylan Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Mylan Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure GSK Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure GSK Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Novartis Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Novartis Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Teve (Actavis) Basic Information List
Table Teve (Actavis) Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teve (Actavis) Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Teve (Actavis) Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Teve (Actavis) Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Lohmann Basic Information List
Table Lohmann Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lohmann Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Lohmann Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Lohmann Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Teikoku Seiyaku Basic Information List
Table Teikoku Seiyaku Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teikoku Seiyaku Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Teikoku Seiyaku Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Teikoku Seiyaku Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Bayer Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Bayer Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Lingrui Basic Information List
Table Lingrui Transdermal Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lingrui Transdermal Drug Delivery System Sales Growth Rate (2012-2017)
Figure Lingrui Transdermal Drug Delivery System Sales Market Share in United States (2012-2017)
Figure Lingrui Transdermal Drug Delivery System Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Qizheng Basic Information List
Table Endo Basic Information List
Table Huarun 999 Basic Information List
Table Haw Par Basic Information List
Table Nichiban Basic Information List
Table Mentholatum Company Basic Information List
Table Laboratoires Genevrier Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Transdermal Drug Delivery System
Figure Manufacturing Process Analysis of Transdermal Drug Delivery System
Figure Transdermal Drug Delivery System Industrial Chain Analysis
Table Raw Materials Sources of Transdermal Drug Delivery System Major Players/Suppliers in 2016
Table Major Buyers of Transdermal Drug Delivery System
Table Distributors/Traders List
Figure United States Transdermal Drug Delivery System Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Transdermal Drug Delivery System Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Transdermal Drug Delivery System Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Transdermal Drug Delivery System Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Transdermal Drug Delivery System Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Transdermal Drug Delivery System Sales Volume (K Units) Forecast by Type in 2022
Table United States Transdermal Drug Delivery System Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Transdermal Drug Delivery System Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Transdermal Drug Delivery System Sales Volume (K Units) Forecast by Application in 2022
Table United States Transdermal Drug Delivery System Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Transdermal Drug Delivery System Sales Volume Share Forecast by Region (2017-2022)
Figure United States Transdermal Drug Delivery System Sales Volume Share Forecast by Region (2017-2022)
Figure United States Transdermal Drug Delivery System Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Gold Nanoparticles Market Insights, Forecast to 2025
    Published: 16-Oct-2018        Price: US 3900 Onwards        Pages: 110
    This report researches the worldwide Gold Nanoparticles market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global Gold Nanoparticles breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributo......
  • 2018-2023 Global Transdermal Drug Delivery Systems Consumption Market Report
    Published: 15-Oct-2018        Price: US 4660 Onwards        Pages: 166
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Transdermal Drug Delivery Systems market for 2018-2023. Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types o......
  • Global Liposome Drug Delivery Market Insights, Forecast to 2025
    Published: 15-Oct-2018        Price: US 3900 Onwards        Pages: 119
    In 2017, the global Liposome Drug Delivery market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Liposome Drug Delivery market based on company, product type, application and key regions. This report studies the global market size of Liposome Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Afr......
  • Global Topical Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 180
    "Delivery of this report will take 1-3 days after purchase." Global Topical Drug Delivery Partnering 2012-2018 provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies Topical Drug Delivery Partnering 2012-2015 report provides understanding and access to the topical drug delivery partnering deals and agreements entered into by the world's leading healthcare companies.......
  • Global Targeted Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 170
    "Delivery of this report will take 1-3 days after purchase." Global Targeted Drug Delivery Partnering 2012-2018 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies Targeted Drug Delivery Partnering 2012-2018 report provides understanding and access to the targeted drug delivery partnering deals and agreements entered into by the world's leading healthcare comp......
  • Global Injectable Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 230
    "Delivery of this report will take 1-3 days after purchase." Global Injectable Drug Delivery Partnering 2012-2018 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies Injectable Drug Delivery Partnering 2012-2015 report provides understanding and access to the injectable drug delivery partnering deals and agreements entered into by the world's leading healthc......
  • Global Transdermal Drug Delivery Partnering 2012-2018: Deal trends, players, financials and forecasts
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 160
    "Delivery of this report will take 1-3 days after purchase." Global Transdermal Drug Delivery Partnering 2012-2018 provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies Transdermal Drug Delivery Partnering 2012-2018 report provides understanding and access to the transdermal drug delivery partnering deals and agreements entered into by the world's leading healthcare......
  • Global Nanotechnology Drug Delivery Market Size, Status and Forecast 2018-2025
    Published: 20-Sep-2018        Price: US 3900 Onwards        Pages: 95
    This report focuses on the global Nanotechnology Drug Delivery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology Drug Delivery development in United States, Europe and China. Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, si......
  • Global Nanotechnology Drug Delivery Market Insights, Forecast to 2025
    Published: 18-Sep-2018        Price: US 3900 Onwards        Pages: 127
    This report studies the global market size of Nanotechnology Drug Delivery in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nanotechnology Drug Delivery in these regions. This research report categorizes the global Nanotechnology Drug Delivery market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, futu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs